Public offering nets $285mm for Blueprint Medicines

15:40 EDT 2 Apr 2019 | Elsevier Business Intelligence

Blueprint Medicines Corp. (precision therapies for cancer and rare diseases) netted $285mm through a public offering of 4mm c...

Original Article: Public offering nets $285mm for Blueprint Medicines

More From BioPortfolio on "Public offering nets $285mm for Blueprint Medicines"